Abstract
Article AbstractLetter to the Editor Sir: We appreciate the comments made by Dr. Swartz on our recent report of electroconvulsive therapy (ECT) in the treatment of atypical depression. We agree that our study was limited due to the lack of a placebo control group and to the use of the 24-item Hamilton Rating Scale for Depression (HAM-D- 24). Without a placebo control, we cannot be certain that ECT was beneficial in treating severely depressed patients with atypical features in the acute phase (i.e., spontaneous improvement could have occurred).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
